Immunity Boosting Food Market by Nature (Organic and Conventional), Product (Super food, Probiotics & Prebiotics, and Dairy Based Products), End Use (Infants & Children and Adults), and Distribution Channel (Supermarkets & Hypermarkets, Convenience Stores, Specialty Stores, and Online Sales Channel): Global Opportunity Analysis and Industry Forecast 2021–2030
- ALL4676986
- 380 Pages
- September 2021
- Food and Beverages
Immunity boosting food is extracted from superfood, probiotics & prebiotics, and dairy based products. It has the potential to protect against age-related diseases. It can be consumed by any age group people.
Immunity boosting food lowers the risk of contracting various diseases in humans. It is also a good source of antioxidants, which help to protect the cardiovascular system by lowering cholesterol levels. It also lowers the risk of stroke and coronary heart disease. As a result of these advantages, the popularity of immunity boosting food is witnessing growth.
However, lack of awareness among the consumers and the high cost of raw materials are limiting the growth of the global immunity boosting food market. The nature of immunity boosting food is perishable, which will pose a challenge to market players.
The pandemic of COVID-19 has raised consumer awareness of the importance of a healthy diet and supplements. Many health supplements and nutraceutical product consist immunity boosting food, which helps to build gut health. As a result, the immunity boosting food market was positively affected, due to the COVID-19 pandemic.
The consumption of immunity boosting food through various superfood also reduces the risk of chronic diseases, which boosts the demand for immunity boosting food from the food and beverage industry and has become a driving factor for the global immunity boosting food market.
The immunity boosting food market is segmented on the basis of nature, product, end use, distribution channel, and region. On the basis of nature, the market is bifurcated into organic and conventional. As per product, the market is divided into superfood, probiotics & prebiotics, and dairy based product. According to end use, the immunity boosting food market is fragmented into infants & children and adults.
On the basis of distribution channel, the market is categorized into supermarkets & hypermarkets, convenience stores, specialty stores, and online sales channel. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (the UK, Finland, Sweden, Denmark, Poland, Italy, and the rest of Europe), Asia-Pacific (China, Japan, India, Singapore, Australia, New Zealand, and the rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and the rest of LAMEA).
North America is witnessing a significant increase in consumer awareness as a result of competitive strategies of the global players. Demand from countries such as the U.S., China, and the UK, is helping to drive the overall growth. Increasing geriatric population combined with rising disposable income and living standards, is expected to contribute to overall growth.
The market is being driven by factors such as rapid growth in the food and beverage industries in developing countries such as Japan and China, as well as increased awareness about the benefits of immunity boosting food products. The major players operating in the global immunity boosting food market are Danone, Nestle, Cargill, ADM, Fonterra group Cooperative Limited, Associated British Foods Plc, Blue Diamond Growers, Diamond Foods, LLC., Dole Food Company Inc., Pinnacle Foods Corp., Olam International, and Hines Nut Company.
KEY BENEFITS FOR STAKEHOLDERS
o This report provides a quantitative analysis of current trends, estimations, and dynamics of the global immunity boosting foods market from 2021 to 2030 to identify the prevailing market opportunities.
o Porter’s five forces analysis highlights the potency of the buyers and suppliers to enable stakeholders to make profit-oriented business decisions and strengthen their supplier–buyer network.
o In-depth analysis of the market segmentation assists to determine the prevailing market opportunities.
o Major countries in each region are mapped according to their revenue contribution to the global industry. The market player positioning segment facilitates benchmarking while providing a clear understanding of the present position of the key market players.
o The report includes analyses of the regional as well as global market, key players, market segments, application areas, and growth strategies.
KEY MARKET SEGMENTS
By Nature
o Organic
o Conventional
By Products
o Superfoods
o Probiotics & Prebiotics
o Dairy based Products
By End Use
o Infants & Children
o Adults
By Distribution Channel
o Supermarkets & Hypermarkets
o Convenience Stores
o Specialty Stores
o Online Sales Channel
By Region
o North America
o U.S.
o Canada
o Mexico
o Europe
o UK
o Finland
o Sweden
o Denmark
o Poland
o Italy
o Rest of Europe
o Asia-Pacific
o China
o Japan
o India
o Singapore
o Australia
o New Zealand
o Rest of Asia-Pacific
o LAMEA
o Brazil
o South Africa
o Saudi Arabia
o Rest of LAMEA
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Snapshot
2.2.Key findings
2.2.1.Top investment pocket
2.3.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key forces shaping global immunity boosting food industry/market
3.2.1.Bargaining power of suppliers
3.2.2.Bargaining power of buyers
3.2.3.Thereat of new entrants
3.2.4.Threat of substitutes
3.2.5.Intensity of competitive rivalry
3.3.Market dynamics
3.3.1.Drivers
3.3.1.1.Increasing consumer awareness about probiotics
3.3.1.2.Growing number of health-conscious consumers
3.3.1.3.Increasing number of chronic diseases and pandemics
3.3.2.Restraints
3.3.2.1.High cost of raw materials and lack of awareness
3.3.2.2.Perishable nature of food
3.3.3.Opportunities
3.3.3.1.Rise in sales through online sales channel
3.3.3.2.Increase in elderly population
3.3.4.COVID-19 Impact Analysis
3.3.5.Player Positioning
Source: Primary Research, Government Publications, and AMR Analysis
CHAPTER 4:GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY NATURE
4.1.Overview
4.1.1.Market size and forecast
4.2.Organic
4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast
4.2.3.Market analysis, by country
4.3.Conventional
4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast
4.3.3.Market analysis, by country
CHAPTER 5:GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT
5.1.Overview
5.1.1.Market size and forecast
5.2.Superfoods
5.2.1.Key market trends, growth factors, and opportunities
5.2.2.Market size and forecast
5.2.3.Market analysis, by country
5.3.Probiotics and Prebiotics
5.3.1.Key market trends, growth factors, and opportunities
5.3.2.Market size and forecast
5.3.3.Market analysis, by country
5.4.Dairy Based Product
5.4.1.Key market trends, growth factors, and opportunities
5.4.2.Market size and forecast
5.4.3.Market analysis, by country
CHAPTER 6:GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY END USE
6.1.Overview
6.1.1.Market size and forecast
6.2.Infants and Children
6.2.1.Key market trends, growth factors, and opportunities
6.2.2.Market size and forecast
6.2.3.Market analysis, by country
6.3.Adults
6.3.1.Key market trends, growth factors, and opportunities
6.3.2.Market size and forecast
6.3.3.Market analysis, by country
CHAPTER 7:GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL
7.1.Overview
7.1.1.Market size and forecast
7.2.Supermarkets & Hypermarkets
7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast
7.2.3.Market analysis, by country
7.3.Convenience stores
7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast
7.3.3.Market analysis, by country
7.4.Specialty Stores
7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast
7.4.3.Market analysis, by country
7.5.Online sales channel
7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast
7.5.3.Market analysis, by country
CHAPTER 8:IMMUNITY BOOSTING FOOD MARKET, BY REGION
8.1.Overview
8.1.1.Market size and forecast
8.2.North America
8.2.1.Key market trends, growth factors, and opportunities
8.2.2.Market size and forecast, by nature
8.2.3.Market size and forecast, by product
8.2.4.Market size and forecast, by end use
8.2.5.Market size and forecast, by distribution channel
8.2.6.Market size and forecast, by country
8.2.7.U.S.
8.2.7.1.Market size and forecast, by nature
8.2.7.2.Market size and forecast, by product
8.2.7.3.Market size and forecast, by end use
8.2.7.4.Market size and forecast, by distribution channel
8.2.8.Canada
8.2.8.1.Market size and forecast, by nature
8.2.8.2.Market size and forecast, by product
8.2.8.3.Market size and forecast, by end use
8.2.8.4.Market size and forecast, by distribution channel
8.2.9.Mexico
8.2.9.1.Market size and forecast, by nature
8.2.9.2.Market size and forecast, by product
8.2.9.3.Market size and forecast, by end use
8.2.9.4.Market size and forecast, by distribution channel
8.3.Europe
8.3.1.Key market trends, growth factors, and opportunities
8.3.2.Market size and forecast, by nature
8.3.3.Market size and forecast, by product
8.3.4.Market size and forecast, by end use
8.3.5.Market size and forecast, by distribution channel
8.3.6.Market size and forecast, by country
8.3.7.UK
8.3.7.1.Market size and forecast, by nature
8.3.7.2.Market size and forecast, by product
8.3.7.3.Market size and forecast, by end use
8.3.7.4.Market size and forecast, by distribution channel
8.3.8.Finland
8.3.8.1.Market size and forecast, by nature
8.3.8.2.Market size and forecast, by product
8.3.8.3.Market size and forecast, by end use
8.3.8.4.Market size and forecast, by distribution channel
8.3.9.Sweden
8.3.9.1.Market size and forecast, by nature
8.3.9.2.Market size and forecast, by product
8.3.9.3.Market size and forecast, by end use
8.3.9.4.Market size and forecast, by distribution channel
8.3.10.Denmark
8.3.10.1.Market size and forecast, by nature
8.3.10.2.Market size and forecast, by product
8.3.10.3.Market size and forecast, by end use
8.3.10.4.Market size and forecast, by distribution channel
8.3.11.Poland
8.3.11.1.Market size and forecast, by nature
8.3.11.2.Market size and forecast, by product
8.3.11.3.Market size and forecast, by end use
8.3.11.4.Market size and forecast, by distribution channel
8.3.12.Italy
8.3.12.1.Market size and forecast, by nature
8.3.12.2.Market size and forecast, by product
8.3.12.3.Market size and forecast, by end use
8.3.12.4.Market size and forecast, by distribution channel
8.3.13.Rest of Europe
8.3.13.1.Market size and forecast, by nature
8.3.13.2.Market size and forecast, by product
8.3.13.3.Market size and forecast, by end use
8.3.13.4.Market size and forecast, by distribution channel
8.4.Asia-Pacific
8.4.1.Key market trends, growth factors, and opportunities
8.4.2.Market size and forecast, by nature
8.4.3.Market size and forecast, by product
8.4.4.Market size and forecast, by end use
8.4.5.Market size and forecast, by distribution channel
8.4.6.Market size and forecast, by country
8.4.7.China
8.4.7.1.Market size and forecast, by nature
8.4.7.2.Market size and forecast, by product
8.4.7.3.Market size and forecast, by end use
8.4.7.4.Market size and forecast, by distribution channel
8.4.8.Japan
8.4.8.1.Market size and forecast, by nature
8.4.8.2.Market size and forecast, by product
8.4.8.3.Market size and forecast, by end use
8.4.8.4.Market size and forecast, by distribution channel
8.4.9.India
8.4.9.1.Market size and forecast, by nature
8.4.9.2.Market size and forecast, by product
8.4.9.3.Market size and forecast, by end use
8.4.9.4.Market size and forecast, by distribution channel
8.4.10.Singapore
8.4.10.1.Market size and forecast, by nature
8.4.10.2.Market size and forecast, by product
8.4.10.3.Market size and forecast, by end use
8.4.10.4.Market size and forecast, by distribution channel
8.4.11.Australia
8.4.11.1.Market size and forecast, by nature
8.4.11.2.Market size and forecast, by product
8.4.11.3.Market size and forecast, by end use
8.4.11.4.Market size and forecast, by distribution channel
8.4.12.New Zealand
8.4.12.1.Market size and forecast, by nature
8.4.12.2.Market size and forecast, by product
8.4.12.3.Market size and forecast, by end use
8.4.12.4.Market size and forecast, by distribution channel
8.4.13.Rest of Asia-Pacific
8.4.13.1.Market size and forecast, by nature
8.4.13.2.Market size and forecast, by product
8.4.13.3.Market size and forecast, by end use
8.4.13.4.Market size and forecast, by distribution channel
8.5.LAMEA
8.5.1.Key market trends, growth factors, and opportunities
8.5.2.Market size and forecast, by nature
8.5.3.Market size and forecast, by product
8.5.4.Market size and forecast, by end use
8.5.5.Market size and forecast, by distribution channel
8.5.6.Market size and forecast, by country
8.5.7.Brazil
8.5.7.1.Market size and forecast, by nature
8.5.7.2.Market size and forecast, by product
8.5.7.3.Market size and forecast, by end use
8.5.7.4.Market size and forecast, by distribution channel
8.5.8.South Africa
8.5.8.1.Market size and forecast, by nature
8.5.8.2.Market size and forecast, by product
8.5.8.3.Market size and forecast, by end use
8.5.8.4.Market size and forecast, by distribution channel
8.5.9.Saudi Arabia
8.5.9.1.Market size and forecast, by nature
8.5.9.2.Market size and forecast, by product
8.5.9.3.Market size and forecast, by end use
8.5.9.4.Market size and forecast, by distribution channel
8.5.10.Rest of LAMEA
8.5.10.1.Market size and forecast, by nature
8.5.10.2.Market size and forecast, by product
8.5.10.3.Market size and forecast, by end use
8.5.10.4.Market size and forecast, by distribution channel
CHAPTER 9:COMPETITION LANDSCAPE
9.1.Top winning strategies
9.2.Product mapping
9.3.Competitive dashboard
9.4.Competitive heat map
9.5.Key developments
9.5.1.Acquisition
9.5.2.Business Expansion
9.5.3.Product Launch
9.5.4.Partnership
9.5.5.Joint venture
CHAPTER 10:COMPANY PROFILES
10.1.Archer-Daniels-Midland Company (ADM)
10.1.1.Company overview
10.1.2.Key Executives
10.1.3.Company snapshot
10.1.4.Operating business segments
10.1.5.Product portfolio
10.1.6.R&D Expenditure
10.1.7.Business performance
10.2.Associated British Foods Plc
10.2.1.Company overview
10.2.2.Key Executives
10.2.3.Company snapshot
10.2.4.Operating business segments
10.2.5.Product portfolio
10.2.6.R&D Expenditure
10.2.7.Business performance
10.2.8.Key strategic moves and developments
10.3.Blue Diamond Growers
10.3.1.Company overview
10.3.2.Key Executives
10.3.3.Company snapshot
10.3.4.Product portfolio
10.3.5.Business performance
10.3.6.Key strategic moves and developments
10.4.Cargill, Inc.
10.4.1.Company overview
10.4.2.Key Executives
10.4.3.Company snapshot
10.4.4.Operating business segments
10.4.5.Product portfolio
10.4.6.Business performance
10.4.7.Key strategic moves and developments
10.5.Danone
10.5.1.Company overview
10.5.2.Key Executives
10.5.3.Company snapshot
10.5.4.Product portfolio
10.5.5.Business performance
10.5.6.Key strategic moves and developments
10.6.Diamond Foods, LLC.
10.6.1.Company overview
10.6.2.Key Executives
10.6.3.Company snapshot
10.6.4.Product portfolio
10.7.Dole Food Company, Inc.
10.7.1.Company overview
10.7.2.Key Executives
10.7.3.Company snapshot
10.7.4.Operating business segments
10.7.5.Product portfolio
10.7.6.Business performance
10.7.7.Key strategic moves and developments
10.8.Hines Nut Company
10.8.1.Company overview
10.8.2.Key Executives
10.8.3.Company snapshot
10.8.4.Product portfolio
10.9.Nestlé S.A
10.9.1.Company overview
10.9.2.Key Executives
10.9.3.Company snapshot
10.9.4.Operating business segments
10.9.5.Product portfolio
10.9.6.R&D Expenditure
10.9.7.Business performance
10.9.8.Key strategic moves and developments
10.10.OLAM INTERNATIONAL LIMITED
10.10.1.Company overview
10.10.2.Key Executives
10.10.3.Company snapshot
10.10.4.Operating business segments
10.10.5.Product portfolio
10.10.6.Business performance
10.10.7.Key strategic moves and developments
TABLE 01.GLOBAL IMMUNITY BOOSTING FOOD MARKET BY NATURE, 2020–2030 ($MILLION)
TABLE 02.ORGANIC IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 03.CONVENTIONAL IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 04.GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 05.SUPERFOODS IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 06.PROBIOTICS AND PREBIOTICS IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 07.DAIRY BASED PRODUCT IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 08.GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 09.INFANTS AND CHILDREN IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 10.ADULTS IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 11.GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 12.IMMUNITY BOOSTING FOOD MARKET FOR SUPERMARKETS & HYPERMARKETS, BY REGION, 2020–2030 ($MILLION)
TABLE 13.IMMUNITY BOOSTING FOOD MARKET FOR CONVENIENCE STORES, BY REGION, 2020–2030 ($MILLION)
TABLE 14.IMMUNITY BOOSTING FOOD MARKET FOR SPECIALTY STORES, BY REGION, 2020–2030 ($MILLION)
TABLE 15.IMMUNITY BOOSTING FOOD MARKET FOR ONLINE SALES CHANNEL, BY REGION, 2020–2030 ($MILLION)
TABLE 16.GLOBAL IMMUNITY BOOSTING FOOD MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 17.NORTH AMERICA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 18.NORTH AMERICA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 19.NORTH AMERICA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 20.NORTH AMERICA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 21.NORTH AMERICA IMMUNITY BOOSTING FOOD MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 22.U.S. IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 23.U.S. IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 24.U.S. IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 25.U.S. IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 26.CANADA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 27.CANADA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 28.CANADA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 29.CANADA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 30.MEXICO IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 31.MEXICO IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 32.MEXICO IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 33.MEXICO IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 34.EUROPE IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 35.EUROPE IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 36.EUROPE IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 37.EUROPE IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 38.EUROPE IMMUNITY BOOSTING FOOD MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 39.UK IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 40.UK IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 41.UK IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 42.UK IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 43.FINLAND IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 44.FINLAND IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 45.FINLAND IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 46.FINLAND IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 47.SWEDEN IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 48.SWEDEN IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 49.SWEDEN IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 50.SWEDEN IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 51.DENMARK IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 52.DENMARK IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 53.DENMARK IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 54.DENMARK IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 55.POLAND IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 56.POLAND IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 57.POLAND IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 58.POLAND IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 59.ITALY IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 60.ITALY IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 61.ITALY IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 62.ITALY IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 63.REST OF EUROPE IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 64.REST OF EUROPE IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 65.REST OF EUROPE IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 66.REST OF EUROPE IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 67.ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 68.ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 69.ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 70.ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 71.ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 72.CHINA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 73.CHINA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 74.CHINA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 75.CHINA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 76.JAPAN IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 77.JAPAN IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 78.JAPAN IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 79.JAPAN IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 80.INDIA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 81.INDIA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 82.INDIA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 83.INDIA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 84.SINGAPORE IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 85.SINGAPORE IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 86.SINGAPORE IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 87.SINGAPORE IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 88.AUSTRALIA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 89.AUSTRALIA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 90.AUSTRALIA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 91.AUSTRALIA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 92.NEW ZEALAND IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 93.NEW ZEALAND IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 94.NEW ZEALAND IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 95.NEW ZEALAND IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 96.REST OF ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 97.REST OF ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 98.REST OF ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 99.REST OF ASIA-PACIFIC IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 100.LAMEA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 101.LAMEA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 102.LAMEA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 103.LAMEA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 104.LAMEA IMMUNITY BOOSTING FOOD MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 105.BRAZIL IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 106.BRAZIL IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 107.BRAZIL IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 108.BRAZIL IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 109.SOUTH AFRICA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 110.SOUTH AFRICA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 111.SOUTH AFRICA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 112.SOUTH AFRICA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 113.SAUDI ARABIA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 114.SAUDI ARABIA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 115.SAUDI ARABIA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 116.SAUDI ARABIA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 117.REST OF LAMEA IMMUNITY BOOSTING FOOD MARKET, BY NATURE, 2020–2030 ($MILLION)
TABLE 118.REST OF LAMEA IMMUNITY BOOSTING FOOD MARKET, BY PRODUCT, 2020–2030 ($MILLION)
TABLE 119.REST OF LAMEA IMMUNITY BOOSTING FOOD MARKET, BY END USE, 2020–2030 ($MILLION)
TABLE 120.REST OF LAMEA IMMUNITY BOOSTING FOOD MARKET, BY DISTRIBUTION CHANNEL, 2020–2030 ($MILLION)
TABLE 121.ADM: KEY EXECUTIVES
TABLE 122.ADM: COMPANY SNAPSHOT
TABLE 123.ADM: OPERATING SEGMENTS
TABLE 124.ADM: PRODUCT PORTFOLIO
TABLE 125.ADM: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 126.ADM: NET SALES, 2018–2020 ($MILLION)
TABLE 127.ASSOCIATED BRITISH FOODS PLC.: KEY EXECUTIVES
TABLE 128.ASSOCIATED BRITISH FOODS PLC.: COMPANY SNAPSHOT
TABLE 129.ASSOCIATED BRITISH FOODS PLC.: OPERATING SEGMENTS
TABLE 130.ASSOCIATED BRITISH FOODS PLC.: PRODUCT PORTFOLIO
TABLE 131.ASSOCIATED BRITISH FOODS PLC.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 132.ASSOCIATED BRITISH FOODS PLC.: NET SALES, 2018–2020 ($MILLION)
TABLE 133.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 134.BLUE DIAMOND GROWERS: KEY EXECUTIVES
TABLE 135.BLUE DIAMOND GROWERS: COMPANY SNAPSHOT
TABLE 136.BLUE DIAMOND GROWERS: PRODUCT PORTFOLIO
TABLE 137.BLUE DIAMOND GROWERS: NET SALES, 2018–2020 ($MILLION)
TABLE 138.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 139.CARGILL, INC.: KEY EXECUTIVES
TABLE 140.CARGILL, INC.: COMPANY SNAPSHOT
TABLE 141.CARGILL, INC.: OPERATING SEGMENTS
TABLE 142.CARGILL, INC.: PRODUCT PORTFOLIO
TABLE 143.CARGILL, INC.: NET SALES, 2018–2020 ($MILLION)
TABLE 144.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 145.DANONE: KEY EXECUTIVES
TABLE 146.DANONE: COMPANY SNAPSHOT
TABLE 147.DANONE: PRODUCT PORTFOLIO
TABLE 148.DANONE: NET SALES, 2018–2020 ($MILLION)
TABLE 149.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 150.DIAMOND FOODS, LLC: KEY EXECUTIVES
TABLE 151.DIAMOND FOODS, LLC: COMPANY SNAPSHOT
TABLE 152.DIAMOND FOODS, LLC: PRODUCT PORTFOLIO
TABLE 153.DOLE FOOD COMPANY, INC.: KEY EXECUTIVES
TABLE 154.DOLE FOOD COMPANY, INC.: COMPANY SNAPSHOT
TABLE 155.DOLE FOOD COMPANY, INC.: OPERATING SEGMENTS
TABLE 156.DOLE FOOD COMPANY, INC.: PRODUCT PORTFOLIO
TABLE 157.DOLE FOOD COMPANY, INC.: NET SALES, 2019–2021 ($MILLION)
TABLE 158.KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 159.HINES NUT COMPANY: KEY EXECUTIVES
TABLE 160.HINES NUT COMPANY: COMPANY SNAPSHOT
TABLE 161.HINES NUT COMPANY: PRODUCT PORTFOLIO
TABLE 162.NESTLÉ S.A.: KEY EXECUTIVES
TABLE 163.NESTLÉ S.A.: COMPANY SNAPSHOT
TABLE 164.NESTLÉ S.A.: OPERATING SEGMENTS
TABLE 165.NESTLÉ S.A.: PRODUCT PORTFOLIO
TABLE 166.NESTLÉ S.A.: R&D EXPENDITURE, 2018–2020 ($MILLION)
TABLE 167.NESTLÉ S.A.: NET SALES, 2018–2020 ($MILLION)
TABLE 168.OLAM INTERNATIONAL, LTD.: KEY EXECUTIVES
TABLE 169.OLAM INTERNATIONAL, LTD.: COMPANY SNAPSHOT
TABLE 170.OLAM INTERNATIONAL, LTD.: OPERATING SEGMENTS
TABLE 171.OLAM INTERNATIONAL, LTD.: PRODUCT PORTFOLIO
TABLE 172.OLAM INTERNATIONAL, LTD.: NET SALES, 2018–2020 ($MILLION)
Similar Reports
According to FAO, aquaculture, also known as aqua farming, is defined as the farming of aquatic organisms such as fish, mollusks, crustaceans, and aquatic plants. Farming implies intervention in the rearing process to enhance production, such as regular stocki...
- Publish Date: December 12, 2016
- $5370
In the year 2015, the global organic food and beverages market accounted for $115,984 million, and is estimated to grow at a CAGR of 16.4% to reach $327,600 million by 2022. Organic foods are produced by organic farming, which uses natural fertilizers and trad...
- Publish Date: December 19, 2016
- $5370
Animal nutrition chemicals are supplements given to animals that corrects deficiencies in feed and dietary supplementation. In addition, animal nutrition chemicals improve animal’s immunity, pregnancy outcome, fertility, newborn survival and growth, meat...
- Publish Date: June 29, 2018
- $5370
